» Articles » PMID: 2172382

CAMP Differentially Regulates Expression of MRNA Encoding IL-1 Alpha and IL-1 Beta in Murine Peritoneal Macrophages

Overview
Journal J Immunol
Date 1990 Nov 15
PMID 2172382
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

The influence of PGE2 and the consequent rise in intracellular cAMP on LPS-induced IL-1 alpha and IL-1 beta mRNA levels has been examined in murine peritoneal macrophages. As has been previously reported, neither PGE2 nor dibutyryl cAMP modulated the levels of LPS-induced IL-1 alpha mRNA. In contrast, the levels of IL-1 beta mRNA were markedly potentiated (greater than 10 fold) under the same experimental conditions. This effect was due to elevation of intracellular cAMP because other agents known to elevate cAMP levels (e.g., cholera toxin, forskolin, 1-isomethyl-3-isobutylxanthine) had the same selective effect on IL-1 beta mRNA levels. PGE2 and dBcAMP not only potentiated LPS-induced IL-1 beta mRNA levels but were also able to stimulate modest accumulation of IL-1 beta mRNA in the absence of LPS. Although measurement of IL-1 activity by bioassay suggested that dBcAMP and PGE2 could suppress LPS-induced IL-1 expression, levels of IL-1 protein, determined by radioreceptor assay, were markedly elevated. cAMP did not appreciably alter the stability of either IL-1 alpha or IL-1 beta mRNA. Instead dBcAMP independently stimulated the transcriptional activity of the IL-1 beta gene. In concert the results demonstrate that cAMP can modulate the response of mononuclear phagocytes to LPS in a complex pattern; gene expression may be unaltered, suppressed, or potentiated and will thereby affect both the quality and magnitude of the ensuing inflammatory response.

Citing Articles

Interleukin-1 associations in inflammatory bowel disease and the enteropathic seronegative spondylarthritis.

Vounotrypidis P, Kouklakis G, Anagnostopoulos K, Zezos P, Polychronidis A, Maltezos E Auto Immun Highlights. 2015; 4(3):87-94.

PMID: 26000147 PMC: 4389024. DOI: 10.1007/s13317-013-0049-4.


Prostaglandin E2 Inhibits NLRP3 Inflammasome Activation through EP4 Receptor and Intracellular Cyclic AMP in Human Macrophages.

Sokolowska M, Chen L, Liu Y, Martinez-Anton A, Qi H, Logun C J Immunol. 2015; 194(11):5472-5487.

PMID: 25917098 PMC: 4433768. DOI: 10.4049/jimmunol.1401343.


Involvement of cyclooxygenase-2--prostaglandin E2 pathway in interleukin-8 production in gastric cancer cells.

Takehara H, Iwamoto J, Iwamoto J, Mizokami Y, Takahashi K, Ootubo T Dig Dis Sci. 2006; 51(12):2188-97.

PMID: 17078003 DOI: 10.1007/s10620-006-9436-2.


Regulation of interleukin-12 gene expression and its anti-tumor activities by prostaglandin E2 derived from mammary carcinomas.

Mitsuhashi M, Liu J, Cao S, Shi X, Ma X J Leukoc Biol. 2004; 76(2):322-32.

PMID: 15123779 PMC: 2965202. DOI: 10.1189/jlb.1203641.


Inhibition by 16,16-dimethyl prostaglandin E2 of tumor necrosis factor-alpha and interleukin-1beta production and messenger RNA expression in human monocytes stimulated by Helicobacter pylori.

Takaishi O, Arakawa T, Fujiwara Y, Fukuda T, Otani K, Yamasaki K Dig Dis Sci. 2000; 44(12):2405-11.

PMID: 10630489 DOI: 10.1023/a:1026614400820.